Registry of acute ischemic stroke patients after endovascular treatment
The Oslo Acute Reperfusion Stroke Study (OSCAR)
Oslo University Hospital · NCT06220981
This study is creating a registry to collect information from people of all ages who have had an acute ischemic stroke and received endovascular treatment, to help improve how strokes are treated in the future.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Oslo University Hospital (other) |
| Locations | 1 site (Oslo) |
| Trial ID | NCT06220981 on ClinicalTrials.gov |
What this trial studies
This observational study aims to create a prospective registry that collects clinical and radiological data from patients who have experienced an acute ischemic stroke and have undergone endovascular treatment. The study will include patients of all ages and stroke severities, focusing on those with cerebral arterial occlusion. By gathering comprehensive data, the study seeks to improve understanding of treatment outcomes and inform future clinical practices in stroke management.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 years or older who have experienced an ischemic stroke and have undergone endovascular revascularization.
Not a fit: Patients who are not eligible for the study or unable to provide informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance treatment strategies and outcomes for patients suffering from acute ischemic stroke.
How similar studies have performed: Other studies have shown success in similar approaches, indicating the potential for valuable insights from this registry.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 years or older * Patients with ischemic stroke and cerebral arterial occlusion treated with endovascular revascularization. * All stroke severities and vascular distributions are eligible. * Informed written consent signed by the patient, verbal consent from the patient as witnessed by a non-participating health care person or consent by the signature of the patient's family must be provided before inclusion. Patients for whom no informed consent can be obtained will not be included in the study but will be treated according to standard guidelines. Exclusion criteria: • Patient not eligible for the study or not available for follow-up assessments (e.g. non- resident).
Where this trial is running
Oslo
- Oslo University Hospital — Oslo, Norway (RECRUITING)
Study contacts
- Study coordinator: Anne Hege Aamodt
- Email: anne.hege.aamodt@gmail.com
- Phone: 97417734
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Acute Ischemic Stroke